Data / Form D filings / Phoreus Biotechnology, Inc.
Phoreus Biotechnology, Inc.: Form D filings
Phoreus Biotechnology, Inc., a biotechnology company in Olathe, KS, filed 7 Form D notices with the SEC between 2018 and 2026. The latest, on March 13, 2026, reports $420,693 sold of an offering with no set size to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 22201 W. INNOVATION DRIVE, Olathe, KS, 66061
- Phone
- (913) 307-7364
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Kansas
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1748964
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | New notice | Indefinite | $420,693 | 3 | Nov 5, 2025 | sec.gov | |
| Mar 13, 2026 | Amendment | Indefinite | $4,434,630 | 49 | Jul 20, 2020 | sec.gov | |
| May 11, 2022 | Amendment | $3,000,000 | $1,929,392 | $1,070,608 | 23 | Jul 20, 2020 | sec.gov |
| May 26, 2020 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| Dec 30, 2019 | Amendment | $1,100,000 | $550,000 | $550,000 | 7 | Jul 30, 2018 | sec.gov |
| Jul 19, 2019 | Amendment | $1,100,000 | $300,000 | $800,000 | 4 | Jul 30, 2018 | sec.gov |
| Aug 2, 2018 | New notice | $1,000,000 | $50,000 | $950,000 | 1 | Jul 30, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Schaefer | Executive Officer, Director, Promoter | |
| Bill Ashley | Director, Promoter | |
| Matthew Tomich | Director, Promoter | |
| Steve Schram | Director, Promoter | |
| Douglas Shane | Director, Promoter | |
| Rajeet Pannu | Director, Promoter | |
| Scott Nagley | Director |
Every Form D from the week of Mar 9, 2026 · All recent filings in Kansas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Phoreus Biotechnology, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.